BioInsights - Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

Cell & Gene Therapy Insights 2022; 8(1), 89–95

10.18609/cgti.2022.026

Published: 22 February 2022
Podcast
Ilaria Scarfone, Mike Brewer

 

Ilaria Scarfone (left), Field Application Specialist, Pharma Analytics, Thermo Fisher Scientific speaks to Mike Brewer, Director and Global Principal Consultant, BioProduction Division, Thermo Fisher Scientific